2007
DOI: 10.1016/j.healthpol.2007.01.012
|View full text |Cite
|
Sign up to set email alerts
|

Effects of essential medicines on cardiovascular products available for the market in Thailand

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
5
0

Year Published

2009
2009
2013
2013

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 29 publications
1
5
0
Order By: Relevance
“…This finding has supported the study hypothesis and confirmed a report that EMs and local manufacturers could increase the market availability of cardiovascular products in Thailand (Burapadaja et al 2007a). The work has also shown that dosage forms of medicines could influence the market availability.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…This finding has supported the study hypothesis and confirmed a report that EMs and local manufacturers could increase the market availability of cardiovascular products in Thailand (Burapadaja et al 2007a). The work has also shown that dosage forms of medicines could influence the market availability.…”
Section: Discussionsupporting
confidence: 92%
“…For anti-infective medicines, their uses are usually for infection, which can be either a non-chronic or chronic condition. In addition, there is a report showing that cardiovascular EMs have a greater number of products available for the market in the country than non-EMs (Burapadaja et al 2007a). As a result, this study proposed that these factors-dosage forms of medicines, targets of distribution, manufacturer types, infective conditions and EM category-would associate with the number of the trade names and products of systemic anti-infective medicines available for the market in the country.…”
Section: Introductionmentioning
confidence: 94%
“…Two surveys, undertaken in the small island states of the South Pacific and in Thailand, reported that the use of an essential drugs list for CVDs helped reduce costs of drugs and improve distribution, 36 as well as control patterns of drug use. 37 Outcomes reported in the latter study, however, were not clear.…”
Section: Interventions and Bottlenecksmentioning
confidence: 74%
“…First, all but 2 studies 36,37 focused on health systems interventions at the organization and program level rather than at the wider systems level. Second, no studies considered interactions between building blocks of the health system, such as, for example, the health financing implications of integrated NCD service delivery models or the health workforce implications of adopting the STEPS instrument in stroke surveillance.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation